Fingerprint
Dive into the research topics of 'Cost-effectiveness of immune checkpoint inhibitors in the treatment of non-small-cell lung cancer as a second line in Taiwan'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cost-effectiveness of immune checkpoint inhibitors in the treatment of non-small-cell lung cancer as a second line in Taiwan
John Hang Leung, Chih Wen Chang, Agnes L.F. Chan, Hui Chu Lang*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review